Detection of antibodies to citrullinated tenascin-C in patients with early synovitis is associated with the development of rheumatoid arthritis

Documenti analoghi

• Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis
  di: Schwenzer, Anja, et al.
  Pubblicazione: (2016)
• Shared recognition of citrullinated tenascin-C peptides by T and B cells in rheumatoid arthritis
  di: Song, Jing, et al.
  Pubblicazione: (2021)
• The relationship between the presence of anti-cyclic citrullinated peptide antibodies and clinical phenotype in very early rheumatoid arthritis
  di: Cader, Mohammed Z, et al.
  Pubblicazione: (2010)
• Time to Include Fine Specificity Anti‐Citrullinated Protein Antibodies in the Routine Diagnosis and Management of Rheumatoid Arthritis?
  di: Schwenzer, Anja, et al.
  Pubblicazione: (2019)
• The role of ultrasound-defined tenosynovitis and synovitis in the prediction of rheumatoid arthritis development
  di: Sahbudin, Ilfita, et al.
  Pubblicazione: (2018)